Syncromune, Inc.
Biotechnology company · Fort Lauderdale, Florida, United States
Syncromune, Inc. is a biotechnology company headquartered in Fort Lauderdale, Florida, United States. Its earliest recorded incorporation is in 2020. It has reported private securities offerings to the US SEC, most recently $145 million sold in a notice filed in 2026.
Syncromune at a glance
What does Syncromune do?
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $144.8 million sold (2026).
Frequently asked questions about Syncromune
Where is Syncromune headquartered?
Syncromune, Inc. is headquartered in Fort Lauderdale, Florida, United States.
What does Syncromune do?
Syncromune, Inc. is a biotechnology company.
When was Syncromune founded?
The earliest incorporation on record for Syncromune, Inc. is in 2020, according to public company registers.
Similar companies
- Veloce BioPharma LLCFort Lauderdale, Florida, United States
- Kaida BioPharma Inc.Fort Lauderdale, Florida, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences